Offering biomedical innovators the experience, expertise, and funding required for success.
Through the RCT Ventures program, venture capital is provided to start-up or early-stage companies with technologies that have the potential to become significant biomedical products with a definite competitive edge. Learn more ›
RCT develops and invests in technologies that enhance and enable the discovery and manufacture of therapeutics and diagnostics. Many of these life science tools are available from RCT through affordable nonexclusive licensing. Learn more ›
GEORGETOWN, TX., September 15, 2026 — AustinPx, a contract development and manufacturing organization (CDMO), today announced that the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) has granted Advanced Manufacturing Technology (AMT) designation to KinetiSol™ Technology. … Learn more